Total Payments
$4,386
2022 Payments
$163.53
Companies
41
Transactions
261
Medicare Patients
3,776
Medicare Billing
$281,072
Payment Breakdown by Category
Food & Beverage$4,009 (91.4%)
Education$377.37 (8.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,009 | 254 | 91.4% |
| Education | $377.37 | 7 | 8.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $809.33 | 54 | $0 (2022) |
| Janssen Biotech, Inc. | $612.86 | 31 | $0 (2022) |
| Dendreon Pharmaceuticals LLC | $461.85 | 20 | $0 (2022) |
| Endo Pharmaceuticals Inc. | $407.54 | 21 | $0 (2021) |
| AbbVie, Inc. | $363.55 | 28 | $0 (2019) |
| PFIZER INC. | $351.24 | 26 | $0 (2022) |
| Blue Earth Diagnostics Limited | $90.96 | 6 | $0 (2021) |
| Myriad Genetic Laboratories, Inc. | $79.07 | 5 | $0 (2022) |
| TOLMAR Pharmaceuticals, Inc. | $78.92 | 5 | $0 (2019) |
| UROGEN PHARMA, INC. | $76.89 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $163.53 | 9 | IBSA Pharma Inc. ($24.62) |
| 2021 | $929.01 | 51 | Janssen Biotech, Inc. ($199.94) |
| 2020 | $602.75 | 28 | Janssen Biotech, Inc. ($222.03) |
| 2019 | $1,184 | 64 | Astellas Pharma US Inc ($243.54) |
| 2018 | $740.25 | 51 | Astellas Pharma US Inc ($170.99) |
| 2017 | $766.80 | 58 | AbbVie, Inc. ($209.29) |
All Payment Transactions
261 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/01/2022 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: ONCOLOGY | ||||||
| 02/23/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Oncology | ||||||
| 02/22/2022 | Myriad Genetic Laboratories, Inc. | Prolaris (Device) | Food and Beverage | Cash or cash equivalent | $11.62 | General |
| Category: Gene Expression Analysis Oncology | ||||||
| 02/09/2022 | IBSA Pharma Inc. | Tirosint (Drug) | Food and Beverage | Cash or cash equivalent | $24.62 | General |
| Category: Endocrinology | ||||||
| 02/04/2022 | Teleflex LLC | UroLift System (Device) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Interventional Urology | ||||||
| 02/02/2022 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Urology Gynecology | ||||||
| 01/26/2022 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Bone Health | ||||||
| 01/13/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Oncology | ||||||
| 01/12/2022 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/21/2021 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Urology Gynecology | ||||||
| 12/15/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: UROLOGY | ||||||
| 12/09/2021 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2021 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $7.26 | General |
| Category: Oncology | ||||||
| 12/06/2021 | Clarus Therapeutics Inc. | JATENZO (Drug), JATENZO, JATENZO | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Testosterone Replacement Therapy | ||||||
| 12/02/2021 | Amgen Inc. | XGEVA (Biological) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Oncology | ||||||
| 11/24/2021 | Blue Earth Diagnostics Limited | Axumin (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: Diagnostic Imaging | ||||||
| 11/10/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: UROLOGY | ||||||
| 10/28/2021 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: ONCOLOGY | ||||||
| 10/26/2021 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Oncology | ||||||
| 10/14/2021 | Alnylam Pharmaceuticals Inc. | OXLUMO (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Genetic Disease | ||||||
| 10/14/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Bone Health | ||||||
| 09/30/2021 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/21/2021 | Teleflex LLC | UroLift System (Device) | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: Interventional Urology | ||||||
| 09/20/2021 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Oncology | ||||||
| 08/25/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 6 | 257 | 284 | $33,493 | $8,973 |
| 2021 | 25 | 1,733 | 2,340 | $394,266 | $135,037 |
| 2020 | 24 | 1,786 | 2,454 | $419,589 | $137,062 |
Total Patients
3,776
Total Services
5,078
Medicare Billing
$281,072
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 64 | 68 | $14,730 | $4,043 | 27.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 16 | 16 | $7,200 | $2,304 | 32.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 45 | 45 | $6,705 | $1,347 | 20.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 19 | $2,782 | $963.22 | 34.6% |
| 81003 | Automated urinalysis test | Office | 2022 | 109 | 124 | $1,536 | $272.66 | 17.8% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 11 | 12 | $540.00 | $42.55 | 7.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 309 | 406 | $87,878 | $37,847 | 43.1% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2021 | 16 | 132 | $74,844 | $19,953 | 26.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 226 | 257 | $38,383 | $16,322 | 42.5% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 75 | 91 | $41,026 | $16,072 | 39.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 111 | 111 | $36,666 | $12,690 | 34.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 41 | 41 | $16,687 | $6,527 | 39.1% |
| 52648 | Laser vaporization of prostate including control of bleeding using an endoscope | Facility | 2021 | 11 | 11 | $18,592 | $6,138 | 33.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 35 | 35 | $7,590 | $2,467 | 32.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 28 | 36 | $5,247 | $2,057 | 39.2% |
| 76770 | Ultrasound behind abdominal cavity | Office | 2021 | 23 | 24 | $10,800 | $2,016 | 18.7% |
| 55700 | Biopsy of prostate gland | Facility | 2021 | 18 | 18 | $9,200 | $1,830 | 19.9% |
| 81003 | Automated urinalysis test | Office | 2021 | 526 | 809 | $9,932 | $1,807 | 18.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 12 | 13 | $3,809 | $1,748 | 45.9% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 44 | 61 | $2,623 | $1,081 | 41.2% |
| 52332 | Insertion of stent in urinary duct (ureter) using an endoscope | Facility | 2021 | 11 | 11 | $6,303 | $1,029 | 16.3% |
| 51702 | Insertion of indwelling bladder catheter, simple | Office | 2021 | 15 | 19 | $2,470 | $933.66 | 37.8% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2021 | 83 | 104 | $4,368 | $754.01 | 17.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 17 | 19 | $1,531 | $579.88 | 37.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 14 | 14 | $1,274 | $540.19 | 42.4% |
About Dr. Peter Carey, M.D
Dr. Peter Carey, M.D is a Urology healthcare provider based in Fredericksburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316994742.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Carey, M.D has received a total of $4,386 in payments from pharmaceutical and medical device companies, with $163.53 received in 2022. These payments were reported across 261 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($4,009).
As a Medicare-enrolled provider, Carey has provided services to 3,776 Medicare beneficiaries, totaling 5,078 services with total Medicare billing of $281,072. Data is available for 3 years (2020–2022), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Fredericksburg, VA
- Active Since 05/30/2006
- Last Updated 01/21/2011
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1316994742
Products in Payments
- PROVENGE (Drug) $478.16
- ERLEADA (Drug) $440.81
- XTANDI (Drug) $414.63
- XIAFLEX (Biological) $362.54
- MYRBETRIQ (Drug) $343.35
- Androgel (Drug) $266.41
- Erleada (Drug) $160.38
- Myrbetriq (Drug) $138.58
- Axumin (Drug) $90.96
- TOVIAZ (Drug) $79.10
- Prolaris (Device) $79.07
- ELIGARD (Drug) $78.92
- JELMYTO (Drug) $76.89
- ORGOVYX (Drug) $69.46
- Nubeqa (Drug) $63.07
- Xtandi (Drug) $54.77
- OXLUMO (Drug) $50.72
- Lupron Depot (Drug) $48.87
- BOTOX (Biological) $47.02
- FIRMAGON (Drug) $41.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Fredericksburg
Daniel Hoffman, M.d, M.D
Urology — Payments: $8,905
Urology $8,905
Dr. Charles Beamon, Md, MD
Urology — Payments: $8,429
Urology $8,429
Gregory Szlyk, M.d, M.D
Urology — Payments: $8,195
Urology $8,195
Frank Hill
Urology — Payments: $7,038
Urology $7,038
Matthew Dumont, M.d, M.D
Urology — Payments: $6,442
Urology $6,442
Elmore Becker, Md, MD
Urology — Payments: $5,610
Urology $5,610